The University of Virginia Cancer Center is conducting a clinical research study for patients who are adults ages 18 and over, and have allogeneic hematopoietic cell transplants. The purpose of this study to evaluate an investigational drug (Viralym-M) versus a placebo in patients with allogeneic hematopoietic cell transplants and may develop viral infections. The effects of the investigational drug will be evaluated for this study.
Participation includes an optional pre-screening visit, a 6 week screening period, about 4 months of treatment, with a longer term follow-up via a clinic visit or a phone call to keep track of how you’re doing. Study specific test will be provided at no cost to you.
Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT04693637
Reimbursement: You will receive up to $175 for hotel stays per night.
You will receive $50 per study visit if you live under 100 miles away. You will be paid the IRS Rate per mile if you live over 100 miles away.